title: Chiasmal optic neuritis following mumps parotitis.
authors.forename: Takashi
authors.initials: T
authors.lastname: Irioka
authors.forename: Miho
authors.initials: M
authors.lastname: Akaza
authors.forename: Keisuke
authors.initials: K
authors.lastname: Nakao
authors.forename: Tadashi
authors.initials: T
authors.lastname: Kanouchi
authors.forename: Takanori
authors.initials: T
authors.lastname: Yokota
authors.forename: Hidehiro
authors.initials: H
authors.lastname: Mizusawa
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D020278:Demyelinating Autoimmune Diseases, CNS / Q000175:diagnosis*; D003937:Diagnosis, Differential; D005260:Female; D006423:Hemianopsia / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage; D009107:Mumps / Q000150:complications*; D009897:Optic Chiasm / Q000473:pathology / Q000503:physiopathology*; D009902:Optic Neuritis / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology*; D010309:Parotitis / Q000150:complications*; D012160:Retina / Q000503:physiopathology; D016896:Treatment Outcome; D014794:Visual Fields
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone